VKTX 250509 26.50C(VKTX250509C26500) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

VKTX250509C26500

Watchlist

2.00
+1.33+198.51%

15min DelayTrading May 9 09:45 ET

2.00High2.00Low

Intraday

5D
Daily

News

Why Viking Therapeutics Stock Was Victorious This Week
Yahoo FinanceMay 2 17:48 ET
Viking Therapeutics Call Volume Above Normal and Directionally Bullish
TipRanksMay 2 15:10 ET
Where Will Viking Therapeutics Be in 3 Years?
Yahoo FinanceMay 2 04:20 ET
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Yahoo FinanceApr 30 04:51 ET
Viking Therapeutics Options Spot-On: On April 29th, 53,329 Contracts Were Traded, With 176.65K Open Interest
Moomoo NewsApr 29 16:30 ET
Viking Among Notable Gainers as Pfizer Raises Deal Prospects
Seeking AlphaApr 29 15:26 ET

Comments

FranC327

May 2 21:45

$Viking Therapeutics (VKTX.US)$

Teddy123

Apr 24 11:17

Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

$Viking Therapeutics (VKTX.US)$
Viking Therapeutics Advances Obesity Drug to Phase 3 with $852M War Chest, Reports Q1 Results

Movers and Shakers

Apr 17 20:16

Columns Today's Pre-Market Movers and Top Ratings | TSM, LLY, UNH and More

Morning Movers
Gapping Up
$Hertz Global (HTZ.US)$ soared 17.2%, building on the previous session's momentum. On Wednesday, the stock had already jumped over 56% after Bill Ackman's Pershing Square revealed a significant investment in the company.
$Eli Lilly and Co (LLY.US)$ surged 10.8% in Thursday's premarket trading following the company's announcement that its oral GLP-1 receptor agonist, orforglipron, achieved the primary endpoi...

Semiconductors earnings is approaching, who will continue the "money-making legend"?

ApexTradeZ

Apr 15 07:47

Buyout Opportunity

$Viking Therapeutics (VKTX.US)$
Could the failure of Pfizer's obesity pill force the drugmaker to spend billions on an acquisition to break into the blockbuster weight-loss market wide open???? VKTX becomes more appealing now but who says HIMS doesnt swoop in before Pfizer does??? $Hims & Hers Health (HIMS.US)$
following closely in the next 1 to 3 months VKTX will advance as more data is set to release from trials and their stock returns to 40-50 with a buyout in the 120 - 150 ra...

FattyChick

Apr 15 02:08

$Viking Therapeutics (VKTX.US)$ Sitting on support.
Should have a mini bounce of 15-20% from here